Almost never. BPC-157, TB-500, sermorelin, and most other popular peptides are not FDA-approved finished drug products. Insurance doesn't cover compounded medications without an FDA-approved equivalent, so peptides are almost universally cash-pay.
Updated May 2026 · 5 min read
Insurance coverage requires FDA approval of a finished drug product for a specific indication. Most peptides are prescribed off-label and dispensed as compounded medications from 503A or 503B pharmacies. Without an FDA-approved equivalent, there is no billing code insurers will accept — making peptide therapy 100% out-of-pocket for virtually all patients.
Insurance almost never covers peptides. These telehealth providers offer physician-supervised protocols with legitimate sourcing.
Get a personalized coverage estimate in 60 seconds based on your insurer, diagnosis, and state.
Check My Coverage →Coverage data is based on publicly available formulary information and reported patient outcomes as of 2026. This is not medical or insurance advice. Always verify coverage directly with your insurer.